Ashween Bilagi

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Protein Protein

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Hittanahallikoppal Gajendramurthy Gowtham, Faiyaz Ahmed, Satish Anandan, C S Shivakumara, Ashween Bilagi, Sushma Pradeep, Chandan Shivamallu, Ali A Shati, Mohammad Y Alfaifi, Serag Eldin I Elbehairi, Raghu Ram Achar, Ekaterina Vladimirovna Silina, Victor Stupin, Mahadevamurthy Murali, Kollur Shiva Prasad
In Silico Computational Studies of Bioactive Secondary Metabolites from Wedelia trilobata against Anti-Apoptotic B-Cell Lymphoma-2 (Bcl-2) Protein Associated with Cancer Cell Survival and Resistance. Molecules (Basel, Switzerland) 28 (4) (2023)
Hittanahallikoppal Gajendramurthy Gowtham, Faiyaz Ahmed, Satish Anandan, C S Shivakumara, Ashween Bilagi, Sushma Pradeep, Chandan Shivamallu, Ali A Shati, Mohammad Y Alfaifi, Serag Eldin I Elbehairi, Raghu Ram Achar, Ekaterina Vladimirovna Silina, Victor Stupin, Mahadevamurthy Murali, Kollur Shiva Prasad
In Silico Computational Studies of Bioactive Secondary Metabolites from Wedelia trilobata against Anti-Apoptotic B-Cell Lymphoma-2 (Bcl-2) Protein Associated with Cancer Cell Survival and Resistance. Molecules (Basel, Switzerland) 28 (4) (2023)
Hittanahallikoppal Gajendramurthy Gowtham, Faiyaz Ahmed, Satish Anandan, C S Shivakumara, Ashween Bilagi, Sushma Pradeep, Chandan Shivamallu, Ali A Shati, Mohammad Y Alfaifi, Serag Eldin I Elbehairi, Raghu Ram Achar, Ekaterina Vladimirovna Silina, Victor Stupin, Mahadevamurthy Murali, Kollur Shiva Prasad
In Silico Computational Studies of Bioactive Secondary Metabolites from Wedelia trilobata against Anti-Apoptotic B-Cell Lymphoma-2 (Bcl-2) Protein Associated with Cancer Cell Survival and Resistance. Molecules (Basel, Switzerland) 28 (4) (2023)